11988
C. Chakraborty et al. / Tetrahedron 63 (2007) 11984–11990
127.9, 128.0, 128.1, 128.3, 128.6, 129.0, 136.7, 137.4, 137.7,
169.5, 170.0. Anal. Calcd for C32H35NO7: C, 70.44; H, 6.47.
Found: C, 70.27; H, 6.62.
4.14 (t, J¼2.4 Hz, 1H, H-1); 13C NMR (75 MHz, D2O)
d 45.6, 50.8, 58.2, 70.0, 71.1, 73.4, 73.8. Anal. Calcd for
C7H15NO5: C, 43.52; H, 7.83. Found: C, 43.80; H, 8.10.
3.3.2. (3aS,4S,5R,6R,7S,7aS)-1-Benzyl-4,6-bis(benzyl-
oxy)-octahydrobenzo[c]isoxazole-5,7-diyl diacetate (7b).
After column chromatography (n-hexane/ethyl acetate¼
4:1), compound 7b was obtained as a white crystalline solid
(0.09 g, 77%). Mp¼136–137 ꢀC; Rf¼0.38 (hexane/ethyl
acetate¼7:3); [a]2D5 ꢁ35.4 (c 0.62, CHCl3); IR (Nujol)¼
3.4.2. (1S,2R,3R,4S,5S,6S)-5-Amino-6-(hydroxymethyl)-
cyclohexane-1,2,3,4-tetraol (2b). Column chromatography
(chloroform/methanol¼1:9) afforded compound 2b as a
semisolid (0.03 g, 85%). [a]2D5 ꢁ86.9 (c 0.07, MeOH); IR
(neat)¼3350, 1417–1454 cmꢁ1; 1H NMR (300 MHz, D2O)
d 1.78–1.90 (m, 1H, H-6), 3.31 (t, J¼9.3 Hz, 1H, H-3),
3.51 (t, J¼3.6 Hz, 1H, H-5), 3.52–3.62 (m, 2H, H-2, H-1)
3.64 (dd, J¼9.3, 3.6 Hz, 1H, H-4), 3.78 (dd, J¼10.8,
7.5 Hz, 1H, H-7a), 3.90 (dd, J¼11.4, 4.2 Hz, 1H, H-7b);
13C NMR (75 MHz, D2O) d 43.2, 51.4, 59.8, 69.2, 72.2,
72.5, 77.32. Anal. Calcd for C7H15NO5: C, 43.52; H, 7.83.
Found: C, 43.86; H, 8.03.
1
1074, 1730 cmꢁ1; H NMR (300 MHz, CDCl3) d 1.90 (s,
3H, CH3), 1.99 (s, 3H, CH3), 2.73 (m, 1H, H-3a), 3.51 (dd,
J¼6.3, 4.5 Hz, 1H, H-7a), 3.75 (dd, J¼8.4, 1.8 Hz, 1H, H-
3), 3.87 (d, J¼13.8 Hz, 1H, N–CH2Ph), 3.91 (t, J¼9.3 Hz,
1H, H-6), 3.94 (dd, J¼8.4, 3.4 Hz, 1H, H-30), 3.99 (d,
J¼13.8 Hz, 1H, N–CH2Ph), 4.02 (t, J¼8.0 Hz, 1H, H-4),
4.55 (d, J¼11.4 Hz, 1H, O–CH2Ph), 4.67 (br s, 3H, O–
CH2Ph), 5.23 (dd, J¼9.0, 8.0 Hz, 1H, H-5), 5.24 (dd,
J¼9.0, 4.5 Hz, 1H, H-7), 7.22–7.36 (m, 15H, Ar–H);
13C NMR (75 MHz, CDCl3) d 18.6 (s), 45.4, 61.0,
61.6, 66.1, 66.9, 71.8, 72.2, 74.1, 74.3, 75.1, 124.8, 125.3,
125.7, 126.0, 126.6, 134.9, 135.6, 167.4 (s). Anal.
Calcd for C32H35NO7: C, 70.44; H, 6.47. Found: C, 70.59;
H, 6.25.
3.4.3. (1S,2S,3R,4S,5R,6R)-5-Amino-6-(hydroxymethyl)-
cyclohexane-1,2,3,4-tetraol (2c). Column chromatography
(chloroform/methanol¼1:9) afforded compound 2c as
a semisolid (0.03 g, 80%). [a]2D5 ꢁ30.7 (c 0.13, MeOH);
IR (neat)¼3352, 1421–1452 cmꢁ1
;
1H NMR (300 MHz,
D2O) d 2.49–2.56 (m, 1H, H-6), 3.20 (dd, J¼11.1 Hz,
4.5 Hz, 1H, H-5), 3.29 (t, J¼9.1 Hz, 1H, H-3), 3.52 (dd,
J¼10.0, 9.1 Hz, 1H, H-2), 3.74 (dd, J¼10.0, 5.5 Hz, 1H,
H-1), 3.77 (dd, J¼11.1, 9.1 Hz, 1H, H-4), 3.86 (dd,
J¼11.8, 7.8 Hz, 1H, H-7a), 3.96 (dd, J¼11.8, 4.2 Hz, 1H,
H-7b); 13C NMR (75 MHz, D2O) d 46.8, 54.8, 59.1, 73.9,
75.7, 75.9, 78.3. Anal. Calcd for C7H15NO5: C, 43.52;
H, 7.83. Found: C, 43.75; H, 7.95.
3.3.3. (3aR,4S,5R,6R,7S,7aR)-1-Benzyl-4,6-bis(benzyl-
oxy)-octahydrobenzo[c]isoxazole-5,7-diyl diacetate (7c).
After column chromatography (n-hexane/ethyl acetate¼
4:1), compound 7c was obtained as a white crystalline solid
(0.09 g, 78%). Mp¼131–133 ꢀC; Rf¼0.25 (hexane/ethyl
acetate¼7:3); [a]2D5 +10.6 (c 0.75, CHCl3); IR (Nujol)¼
1
1070, 1700 cmꢁ1; H NMR (300 MHz, CDCl3) d 1.90 (s,
3.5. General procedure for the conversion of 2 to 8
3H, CH3), 1.99 (s, 3H, CH3), 3.12 (br dd, J¼9.3, 8.0 Hz,
1H, H-7a), 3.29–3.38 (m, 1H, H-3a), 3.43 (t, J¼9.3 Hz, 1H,
H-6), 3.73 (d, J¼14.1 Hz, 1H, N–CH2Ph), 3.75 (dd, J¼8.7,
6.0 Hz, 1H, H-4), 4.08 (t, J¼8.7 Hz, 1H, H-3), 4.14 (d,
J¼14.1 Hz, 1H, N–CH2Ph), 4.22 (t, J¼8.7 Hz, 1H, H-30),
4.58 (ABq, J¼11.7 Hz, 2H, O–CH2Ph), 4.65 (br s, 2H, O–
CH2Ph), 5.30 (t, J¼9.3 Hz, 1H, H-7), 5.40 (t, J¼8.7 Hz,
1H, H-5), 7.22–7.43 (m, 15H, Ar–H); 13C NMR (75 MHz,
CDCl3) d 20.8 (s), 41.7, 60.5, 64.2, 67.4, 72.2 (s), 72.4,
73.5, 75.2, 78.8, 127.5, 127.7, 127.8, 128.2, 128.3, 128.8,
136.5, 137.6, 137.8, 169.2, 169.5. Anal. Calcd for
C32H35NO7: C, 70.44; H, 6.47. Found: C, 70.28; 6.33.
A solution of compound 2 (0.02 g, 0.09 mmol) in 0.5 M HCl
(1 mL) in methanol was stirred at room temperature for 20 h.
The solvent was evaporated under reduced pressure and res-
idue was dried in vacuo. The residue was washed with dry
ether and ethyl acetate.
3.5.1. (1R,2R,3R,4S,5R,6R)-5-Amino-6-(hydroxymethyl)-
cyclohexane-1,2,3,4-tetraol hydrochloride (8a). Com-
pound was dried in vacuo to afford the hydrochloride salt
8a (0.02 g, 0.09 mmol) as a semisolid. [a]2D5 ꢁ100.0
1
(c 0.12, MeOH); IR (neat)¼3440, 1454 cmꢁ1; H NMR
(300 MHz, D2O) d 2.53–2.57 (m, 1H, H-6), 3.58 (dd,
J¼9.9, 3.3 Hz, 1H, H-2), 3.61–3.85 (m, 5H, H-5, H-4, H-
3, H-7a, H-7b), 4.12 (t, J¼3.0 Hz, 1H, H-1); 13C NMR
(75 MHz, D2O) d 43.7, 51.9, 58.7, 69.8, 70.4, 71.0, 73.7.
Anal. Calcd for C7H16ClNO5: C, 36.61; H, 7.02. Found: C,
36.52; H, 7.19.
3.4. General procedure for the conversion of 6 to 2
To a well-stirred solution of compound 6 (0.1 g, 0.20 mmol)
in dry methanol (5 mL) were added 10% Pd/C (0.1 g) and
ammonium formate (0.9 g, 1.41 mmol). The reaction was
heated at reflux for 45 min. The reaction mixture was filtered
through Celite and solvent was evaporated to give a sticky
solid. The residue was washed with dry ether and ethyl
acetate.
3.5.2. (1S,2R,3R,4S,5S,6S)-5-Amino-6-(hydroxymethyl)-
cyclohexane-1,2,3,4-tetraol hydrochloride (8b). Com-
pound was dried in vacuo to afford the hydrochloride salt
8b (0.02 g, 0.09 mmol) as a semisolid. [a]2D5 ꢁ42.8
1
3.4.1. (1R,2R,3R,4S,5R,6R)-5-Amino-6-(hydroxymethyl)-
cyclohexane-1,2,3,4-tetraol (2a). Column chromatography
(chloroform/methanol¼1:9) afforded 2a as a semisolid
(0.03 g, 84%). [a]2D5 ꢁ114.2 (c 0.04, MeOH); IR (neat)¼
(c 0.07, MeOH); IR (neat)¼3330, 1456 cmꢁ1; H NMR
(300 MHz, D2O) d 1.96–2.21 (m, 1H, H-6), 3.38 (t,
J¼9.3 Hz, 1H, H-2), 3.49 (t, J¼9.3 Hz, 1H, H-3), 3.69 (dd,
J¼11.4, 9.3 Hz, 1H, H-1), 3.81–3.86 (m, H-1, 2H, H-4),
3.89 (dd, J¼11.7, 3.0 Hz, 1H, H-7a), 3.98 (dd, J¼11.7,
5.4 Hz, 1H, H-7b); 13C NMR (75 MHz, D2O) d 40.6, 54.0,
58.9, 67.4, 69.6, 72.0, 76.4. Anal. Calcd for C7H16ClNO5:
C, 36.61; H, 7.02. Found: C, 36.45; H, 6.91.
1
3433, 1417 cmꢁ1; H NMR (300 MHz, D2O) d 2.32–2.36
(m, 1H, H-6), 3.26 (dd, J¼10.8, 5.4 Hz, 1H, H-5),
3.48 (dd, J¼10.8, 7.2 Hz, 1H, H-4), 3.55–3.62 (m, 3H,
H-3, H-2, H-7a), 3.82 (dd, J¼11.4, 6.0 Hz, 1H, H-7b),